Hopp til innhold

Selected items added to basket

Go to basket

Project

Controlled donation after circulatory death (cDCD) using normothermic regional perfusion in patients who die after withdrawal of life sustaining treatment - project description

Published Updated


An HTA on organ donation with the use of normothermic regional perfusion in patients who die of cardiac and respiratory arrest after withdrawal of life-sustaining treatment.


Have you found an error?

Summary

The Norwegian Institute of Public Health has been commissioned by “Ordering Forum, Regional Health Authorities (RHF) in the National System for Managed Introduction of New Health Technologies (within the Specialist Health Service in Norway)” to prepare an HTA on organ donation with the use of normothermic regional perfusion in patients who die of cardiac and respiratory arrest after withdrawal of life-sustaining treatment. The HTA will contain three domains: effectiveness and safety in addition to legal and ethical consequences. The legal and ethical issues and consequences will be the most important domains.

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Liv Giske, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health

Project participants

Eva Helene Arentz-Hansen, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health
Elisabet Vivianne Hafstad, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health